Physician profile
Neil Mansdorf
NPI 1295766475
$5,372.26
in general payments reported to CMS, 2019-2025
29 companies · $907 in 2025
The $907 reported for 2025 was more than what 86% of Sports Medicine (Podiatrist) providers received nationally (typical 2025 total: $307).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $779 · 2020: $477 · 2021: $935 · 2022: $679 · 2023: $1,011 · 2024: $585 · 2025: $907.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,502.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,502.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $943.52 | 2019-2025 | Prophecy, Prostep Mica, Augment Injectable |
| Treace Medical Concepts, INC. | $535.53 | 2020-2025 | |
| Pfizer INC. | $515.41 | 2019-2021 | |
| Horizon Therapeutics Plc | $400.44 | 2019-2023 | Krystexxa |
| Inari Medical, INC. | $383.37 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic, INC. | $284.47 | 2023-2025 | Abre, Inceptiv |
| Boston Scientific Corporation | $228.14 | 2019-2021 | |
| Paratek Pharmaceuticals, INC. | $215.94 | 2022-2025 | Nuzyra |
| Heron Therapeutics, INC. | $195.89 | 2021-2022 | |
| Grt US Holding, INC. | $176.83 | 2022 | |
| Smith+Nephew, INC. | $172.96 | 2019-2025 | Collagenase Santyl |
| Paragon 28, INC. | $154.15 | 2019-2025 | Precision Mis Bunion |
| Abbott Laboratories | $149.78 | 2023 | Eterna |
| Organogenesis INC. | $140.74 | 2021-2023 | Puraply |
| Tactile Systems Technology INC | $136.74 | 2019-2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $127.57 | 2024-2025 | Hammerlock, Na |
| Zimmer Biomet Holdings, INC. | $115.30 | 2020-2021 | |
| Amgen INC. | $103.82 | 2024-2025 | Krystexxa |
| Bioventus LLC | $78.99 | 2021-2025 | Exogen Ultrasound Bone Healing System |
| Wright Medical Technology, INC. | $62.74 | 2019-2020 | |
| Biotissue Holdings INC. | $52.22 | 2022-2024 | |
| Integra Lifesciences Corporation | $44.46 | 2019-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Forte Bio-Pharma LLC | $39.18 | 2019 | |
| Fusion Orthopedics USA, LLC | $23.82 | 2024 | |
| Acumed LLC | $23.80 | 2022 | |
| Averitas Pharma INC. | $20.42 | 2023 | Qutenza |
| Reprise Biomedical, INC. | $18.90 | 2024 | Miro3d |
| Kerecis Limited | $14.89 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $12.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil Mansdorf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.